Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
TRuE-VIP1 Study - Ruxolitinib cream for children ages 2-11 with vitiligo
Official title: A Phase 3, Randomized, Double-Blind, Safety, and Efficacy Study of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
Status: Recruiting now
Description:
This Phase 3 study is evaluating the safety and efficacy of ruxolitinib 1.5% cream in children ages 2–11 with nonsegmental vitiligo.
During the first 24 weeks, participants receive ruxolitinib cream or a matching cream (called "vehicle") with no active medicine. Study cream is applied twice daily.
Participation continues for up to 52 weeks, followed by a safety follow-up.
Basic eligibility includes measurable nonsegmental vitiligo on the face and body: at least 0.5% of body surface area on the face and at least 2% on nonfacial areas, with no more than 10% total body involvement. Other criteria apply, including requirements concerning current and recent vitiligo treatments.
Sites are located in the United States and Canada. The research site determines eligibility.
Use of ruxolitinib cream for vitiligo in this age group is investigational.
🔎 See if your child is eligible here
Related pediatric study: View the study for children ages 6–11 in Argentina and Europe (recruitment closed)
Start date: January 24, 2025
Completion date: March 13, 2027
Organizer: Incyte Corporation
Contact: Incyte Corporation Call Center (US)
Tel.: +1-855-463-3463
Email: medinfo@incyte.com
Clinical Trial Alerts
Sign up and be the first to know about updates on this trial.
FAQOther Questions
- How smoking affects vitiligo?
Smoking is a common habit linked to numerous health risks, affecting multiple body systems and increasing various disease risks, including respiratory and cardiovascular issues....
- What are the best predictors for therapy response in vitiligo?
A fair question. Also a slightly annoying one, because dermatology loves nuance and patients usually want something more like a weather forecast. Still, a few factors do show up...
- Shall I try low-fat diet for my vitiligo?
The link between dietary fat and autoimmune diseases like vitiligo is a compelling yet complex puzzle that continues to intrigue scientists. While the conversation is ongoing, o...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.